Clinical trial
Post-ERCP Pancreatitis Severity Indication (PEPSI) Study
NCT03075592 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-ERCP Pancreatitis Severity Indication (PEPSI) Study
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 22, 2009
- Completion date
- November 22, 2019
- Enrollment
- 48 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.